ArticleChemical science2025
Synergistic engineering of ultraviolet metal-free crystals with exceptional birefringence
Article in Chemical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Rigid-Flexible Coupling Units Enable Robust Large Birefringence.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Exceptional Enhancement of Optical Anisotropy Achieved via the Strategy of Combining Rigid Groups with High Symmetry and π-Conjugated Organic Groups in Hybrid Fluorides.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Crystals with giant birefringence are essential for practical applications in lasers, optical communication, and polarimetry, where precise control of polarized light is critical. Coplanar six-membered ring (6-MR) primitives with large polarizability anisotropy are particularly effective in enhancing birefringence. This study successfully combines different pyridine derivatives into two novel metal-free crystals: supramolecular one-dimensional [(4-HP)(4-H
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.